Latest News
Featured News
Director Dealing
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting
Issue of share options to Non-Executive Directors
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting
Block Listing Application to AIM
Scancell Statement re: Silicon Valley Bank (SVB)
Encouraging early efficacy data from monotherapy part of ModiFY Phase 1/2 clinical trial
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.